Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
31.50
-0.47 (-1.47%)
At close: Sep 18, 2026, 4:00 PM EDT
32.13
+0.63 (2.00%)
After-hours: Sep 18, 2026, 7:45 PM EDT
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $2.05 billion as of September 18, 2026. Its market cap has increased by 155.73% in one year.
Market Cap
2.05B
Enterprise Value
1.71B
1-Year Change
155.73%
Ranking
Category
Stock Price
$31.50
ChartMarket Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $2.05B, an increase of 203.50%. That is a compound annual growth rate of 73.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.05B | 5.33% |
| Dec 31, 2025 | 1.95B | 469.46% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Trevi Therapeutics | 2.13B |
| Sarepta Therapeutics | 2.12B |
| UroGen Pharma | 2.11B |
| Biohaven | 2.06B |
| Nuvation Bio | 2.05B |
| Recursion Pharmaceuticals | 2.05B |
| Kodiak Sciences | 2.05B |
| Vericel | 2.05B |